NFKB1 and hepatocellular carcinoma: As AGK is aberrantly expressed in HCC and contributes significantly to constitutive NF-κB signaling activation, targeting AGK may provide an effective strategy for inhibiting NF-κB signaling - and its subsequent effects on angiogenesis and resistance to apoptosis - during the treatment of HCC.